- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Dendreon Corp+ Add to Watchlist
DNDN:US3.3200 USD 0.0600 1.78%
As of 17:20:00 ET on 12/20/2013.
Company Profile for Dendreon Corp (DNDN)
Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.
Key Executives for Dendreon Corp (DNDN)
|John H JohnsonChairman/President/CEO||Lindsay RoccoExec VP:Corporate Communications|
|Joseph I Depinto "Joe"Exec VP:Global Commercial Ops||Mark W FrohlichExec VP:Research & Dev|
|William MonteithExec VP:Technical Operations||Christine MikailExec VP:Dev/Secy/Gen Cnsl|
|Gregory R CoxVP:Finance/Interim CFO|